Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis

Summary

Brief summary: This study compares the long-term efficacy and safety of interferon (IFN) α2a and cyclosporine (cyclosporin A, CsA) following suppression of acute attack by high-dose oral glucocorticosteroid in patients with refractory Behçet's uveitis (BDU). Half of the participants will receive IFNα2a while the other half will receive CsA.

Timeline

Start

2017-06-30

Primary completion

2020-08-31

Completion

2021-01-31

Drugs

Indications